Form D — Maxona Pharmaceuticals, Inc.
0001857448-26-000002 · filed Aug 14, 2026
Offering
- Industry
- Pharmaceuticals
- Exemptions
- 06b
- Total offering
- $12,000,000
- Total sold
- $5,778,673
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Maxona Pharmaceuticals, Inc.
- CIK
- 1857448
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 101 Lindenwood Drive
Malvern, PA 19355 - Phone
- 484.681.5626
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Shahin Fatholahi · Executive OfficerMalvern, PA Find on LinkedIn ↗
-
Behshad Sheldon · DirectorMalvern, PA Find on LinkedIn ↗
-
David Nakamura · DirectorMalvern, PA Find on LinkedIn ↗
-
Richard Brand · Executive OfficerMalvern, PA Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗